The U.S. Food and Drug Administration (FDA) issued a draft guidance titled Data Standards for Drug and Biological Product Submissions Containing Real-World Data on October 21, 2021. The guidance ...
The European Medicines Agency (EMA) has finalized a document with recommendations on using the European Medicines Regulatory Network (EMRN) Data Quality Framework (DQF) when submitting premarket ...
Rare diseases affect fewer than 200,000 people in the U.S., approximately 30 million individuals. Sadly, 3 out of 10 children with a rare disease won’t live to see their fifth birthday, yet the path ...
In this work, a multi-stakeholder group coordinated by the Gesellschaft für Pharmazeutische Medizin (GPMed, Austrian Society for Pharmaceutical Medicine) compiled and classified already used national ...
Industry leaders want to see more flexibility and clarity from the US Food and Drug Administration (FDA) as it seeks to finalize guidance on the use real-world data (RWD) from electronic health ...
The global pandemic has accelerated the Food and Drug Administration’s (FDA) encouragement of real-world data (RWD) and real-world evidence (RWE) (the clinical evidence derived from analysis of RWD), ...
A growing body of research is focusing on real-world data (RWD) to supplement or replace randomized controlled trials (RCTs). However, due to the disparities in data generation mechanisms, differences ...
Interviews conducted with biopharma executives in a Tufts CSDD study reveals growing RWD adoption and ROI across all phases of drug development SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results